Welcome to the Bioasis Technologies Hub On AGORACOM

Free
Message: XOMA Acquires Royalty Interest in Four Lysosomal Storage Disorder Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance

"Can anyone make sense of this?"

 

Does it make sense to generate cash for the development of XB3 001?  Yes.

How much did the market value the $138M milestone payment figure?  I would say only a token amount, it was very heavily discounted.

I suspect there may be another shoe to drop.  No press release,so far, from BTI

Share
New Message
Please login to post a reply